← Every company
Takeda Pharmaceutical Co Ltd Lobbying
What Takeda Pharmaceutical Co Ltd discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
TAK on carbonthat →Disclosed spend
$2.6M
across every filing on file
Filings
19
Years covered
1
Firms retained
4
What it lobbies about
Taxation/Internal Revenue CodeHealth IssuesMedicare/MedicaidCopyright/Patent/TrademarkTrade (domestic/foreign)Environment/Superfund
19 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | TAKEDA PHARMACEUTICALS AMERICA, INC.Budget/AppropriationsMedicare/Medicaid | $1.4M |
| 20262nd Quarter (Apr 1 - June 30) | TAKEDA PHARMACEUTICALS AMERICA, INC.Budget/AppropriationsMedicare/Medicaid | $610K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPMedicare/MedicaidHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK GROUPMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLCHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | HOLLAND & KNIGHT LLPTaxation/Internal Revenue Code | $50K |
| 20262nd Quarter (Apr 1 - June 30) | CROSSROADS STRATEGIES, LLCHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | HOLLAND & KNIGHT LLPTaxation/Internal Revenue Code | $50K |
| 20262nd Quarter (Apr 1 - June 30) | FARRAGUT PARTNERS LLPHealth Issues | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | FARRAGUT PARTNERS LLPHealth Issues | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | PORTERFIELD, FETTIG & SEARS, LLCHealth Issues | $30K |
| 20262nd Quarter (Apr 1 - June 30) | AVENUE SOLUTIONSHealth Issues | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | MR. BRIAN KELLY | — |
| 20261st Quarter (Jan 1 - Mar 31) | FARRAGUT PARTNERS LLPHealth Issues | — |
| 20262nd Quarter (Apr 1 - June 30) | AVENUE SOLUTIONSHealth Issues | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on TAK
Company overviewEverything on TAK in one place, with the price.SEC filingsWhat TAK's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat TAK's own officers and directors buy and sell.Who owns itEvery manager reporting a position in TAK.Funds holding itWhich funds and ETFs hold TAK, and how big a bet.Who lobbies for itThe lobbyists on TAK's account, and who they worked for.PatentsWhat TAK is filing at the patent office.